Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Respiratory Medicine

Respiratory Medicine current awareness bulletin

Frequency: Bi-monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email:

July 2024

Adherence in paediatric respiratory medicine: a review of the literature 10.1016/j.prrv.2023.09.004

Association of active mobilisation variables with adverse events and mortality in patients requiring mechanical ventilation in the intensive care unit: a systematic review and meta-analysis 10.1016/S2213-2600(24)00011-0

Behaviour change interventions for physical activity in adults with chronic obstructive pulmonary disease: a systematic review and meta-analysis 10.1016/j.resmer.2023.101068

Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise 10.1016/S2213-2600(24)00028-6

COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms 10.1111/crj.13790

Efficacy of neoadjuvant chemotherapy combined with surgery in patients with nonsmall cell lung cancer: a meta-analysis 10.1111/crj.13756

Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trials 10.1016/S2213-2600(24)00041-9

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: a review 10.1111/crj.13777 

Expiratory airflow limitation in adults born extremely preterm: a systematic review and meta-analysis 10.1016/j.prrv.2024.02.002

High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study 10.1016/S2213-2600(23)00267-9

Interstitial lung disease: a review 10.1001/jama.2024.3669

Interventions for smoking cessation in hospitalised patients (updated Cochrane review) 10.1002/14651858.CD001837.pub4

Leveraging the pleural space for anticancer therapies in pleural mesothelioma 10.1016/S2213-2600(24)00111-5

Musculoskeletal aspects of respiratory function in cystic fibrosis: a cross-sectional comparative study 10.1080/20018525.2024.2350206

Neurodevelopmental outcomes of extremely preterm infants with bronchopulmonary dysplasia (BPD) – a retrospective cohort study 10.1016/j.prrv.2024.02.004

Racial and skin color mediated disparities in pulse oximetry in infants and young children 10.1016/j.prrv.2023.12.006

The relationship of gastroesophageal reflux disease and asthma control 10.1080/20018525.2024.2348267


Clinical Respiratory Journal, The (May-Jun); Cochrane Library (May-Jun); European Clinical Respiratory Journal (May); JAMA (22nd Apr); Lancet Respiratory Medicine, The (May-Jun); Paediatric Respiratory Reviews (Jun); Respiratory Medicine and Research (Jun)

May 2024

Behavioral interventions and symptom cluster change in adults with chronic obstructive pulmonary disease and insomnia 10.1016/j.hrtlng.2023.11.001

Correlation between peripheral endothelial function, oxygen consumption and ventilatory efficiency in heart transplantation recipients 10.1016/j.hrtlng.2023.11.008

Effectiveness of aspirin on major COPD outcomes 10.1080/15412555.2024.2317380 

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia 10.1016/S2213-2600(23)00414-9

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: a network meta-analysis 10.1111/crj.13745

High‐flow nasal cannula therapy for infants with bronchiolitis (updated Cochrane intervention review) 10.1002/14651858.CD009609.pub3

Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV) 10.1016/S2213-2600(23)00346-6

Lung cancer: diagnosis and management (updated NICE guideline NG122)

Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH) 0.1016/S2213-2600(23)00432-0

Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (updated NICE guideline TA878)

Obstructive sleep apnea and vitamin D level: has the dust settled? 10.1111/crj.13593  

Oxygen debt as a predictor of high-flow nasal cannula therapy failure in SARS-CoV-2 patients with acute respiratory failure: A retrospective cohort study 10.1016/j.hrtlng.2023.10.013

Pleural fluid characteristics of patients with COVID-19 infection 10.1111/crj.13744 

Radiographic findings of adenoviral pneumonia in children 10.1016/j.clinimag.2024.110111

Real-world effectiveness of single-inhaler triple therapy for COPD: impact of diabetes comorbidity 10.1080/15412555.2024.2327345

Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis 10.1016/S2213-2600(23)00408-3

Shaping urban environments to improve respiratory health: recommendations for research, planning, and policy 10.1016/S2213-2600(23)00329-6

Therapeutic vaccines for advanced non‐small cell lung cancer (new Cochrane intervention review) 10.1002/14651858.CD013377.pub2


Clinical Imaging (Apr-May); Clinical Respiratory Journal, The (Mar-Apr); Cochrane Library (Mar); COPD: Journal of Chronic Obstructive Pulmonary Disease (Mar); Heart and Lung (Mar-Apr); Lancet Respiratory Medicine, The (Mar-Apr); NICE website (Mar-Apr)

March 2024

3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study DOI: 10.1016/S2213-2600(23)00387-9

Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION) DOI: 10.1016/S2213-2600(23)00303-X

Beyond spirometry: linking wasted ventilation to exertional dyspnea in the initial stages of COPD DOI: 10.1080/15412555.2023.2301549

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2) DOI: 10.1016/S2213-2600(23)00298-9

Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case–control study DOI: 10.1016/S2213-2600(23)00306-5

Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial DOI: 10.1016/S2213-2600(23)00376-4

Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial DOI: 10.1016/S2213-2600(23)00082-6

Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome (updated Cochrane intervention review) DOI: 10.1002/14651858.CD008309.pub3

Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated neonates (new Cochrane intervention review) DOI: 10.1002/14651858.CD013353.pub2

Optimizing emergency department imaging utilization for pulmonary emboli: A study on the effects of IV contrast rationing DOI: 10.1016/j.clinimag.2024.110090

Postoperative CT surveillance in the evaluation of local recurrence after sub-lobar resection of neoplastic lesions of the lung DOI: 10.1016/j.clinimag.2023.110030

Preoperative pulmonary nodule localization: A comparison of hook wire and Lung-pro-guided surgical markers DOI: 10.1111/crj.13726

The role of bioactive small molecules in COPD pathogenesis DOI: 10.1080/15412555.2024.2307618

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial DOI: 10.1016/S2213-2600(23)00349-1

Safety outcomes of salbutamol: A systematic review and meta-analysis DOI: 10.1111/crj.13711

Unravelling the respiratory health path across the lifespan for survivors of preterm birth DOI: 10.1016/S2213-2600(23)00272-2

Sources used: Clinical Imaging (Jan-Mar); Clinical Respiratory Journal, The (Dec-Feb); Cochrane Library (Jan-Feb); COPD: Journal of Chronic Obstructive Pulmonary Disease (Feb); Lancet Respiratory Medicine, The (Dec-Feb)